Botulinum Toxin Treatment

Very few therapeutic agents in clinical medicine have found indication for so many clinical conditions, and in such a short time as did botulinum neurotoxins (Botox and others).  Chronic migraine, bladder dysfunction , dystonia, hemifacial spasm , blepharospasm , drooling, excessive sweating and  spasticity are all approved by FDA  and many other indications are in the near horizon .  The aesthetic/cosmetic use of Botox and other BoNTs already has a huge market worldwide. Stroke, Multiple sclerosis, Parkinson's disease, Cerebral palsy as well as brain and  spinal injury are among clinical conditions in which some of  patients' major symptoms can respond to botulinum toxin therapy 

Several books have been written on the subject of Botox and other neurotoxins for treatment of  medical disorders ( including two books by Jabbari both published by Springer 2015 & 2017).  However, despite the huge interest and enthusiasm of the public to learn more about Botox and other toxins, there is currently no book in the market on this subject which is specifically designed to inform and educate the public on botulinum toxin therapy. Botulinum Toxin Treatment explains and discusses in simple language the structure and function of botulinum toxin and other neurotoxins as well as the rational for its utility in different disease conditions. Safety, factors affecting efficacy and duration of action, as well as cost and insurance issues are also addressed.

Bahman Jabbari M.D. is Emeritus Professor of Neurology, Yale University School of Medicine, Director of Botulinum Treatment Program, Yale University (2005-2015). His experience with botulinum toxin therapy with a large volume of patients extends over 25 years, and he has written extensively on the role of botulinum toxin therapy in clinical medicine.